Tasly's Smart Manufacturing Practices Drive New Quality Productive Forces at the 4th International Conference on Traditional Chinese Medicine Development in Tianjin

2024Year5Month9Recently, the “Digital Intelligence Empowering New Quality Productive Forces in the Big Health Industry and the 4th International Conference on Traditional Chinese Medicine Development” was successfully held at Tasly in Tianjin.

The Central Economic Work Conference explicitly stated that industrial innovation should be driven by scientific and technological innovation, particularly by leveraging disruptive and frontier technologies to foster new industries, new models, and new growth drivers, thereby developing new quality productive forces. In thorough implementation of this important directive, the conference empowered the high-quality development of the big health industry through digital, information-based, and intelligent scientific and technological innovations.

At the sub-forum on “Intelligent Manufacturing Promoting the International Development of Traditional Chinese Medicine,” held on the afternoon of May 9, Wang Yuefei, Deputy Director of the State Key Laboratory of Modern Chinese Medicine Innovation, pointed out that fostering new quality productive forces requires concerted efforts in three areas: “original and disruptive technological innovation from 0 to 1,” “industrial innovation from 1 to 100,” and “innovation in industrial development models from 100 to 10,000.”

Wang Yuefei also spoke highly of a group of modern traditional Chinese medicine (TCM) enterprises, represented by Tasly, for their proactive efforts in developing new quality productive forces. By seizing opportunities and taking the initiative, these companies have deeply integrated advanced manufacturing technologies, big data, and artificial intelligence with the traditional TCM pharmaceutical industry, achieving improved quality and efficiency, iterative upgrades, and green, high-quality development.

At the conference, Zhang Shunnan, Deputy General Manager of Tasly Pharmaceutical Group Co., Ltd., delivered a keynote speech titled “Developing New Quality Productive Forces in the Traditional Chinese Medicine Industry: Tasly’s Practices in Digital-Intelligent TCM and Smart Manufacturing.” He shared detailed case studies on Tasly’s smart manufacturing technology system and its industrial translation achievements aimed at digital-intelligent TCM, providing valuable practical experience for the high-quality development of the TCM industry through intelligent, high-end, and green transformation.

Zhang Shunnan emphasized that manufacturing is the critical link connecting scientific research and the market in the traditional Chinese medicine (TCM) industry, serving as the foundation for enterprises to ensure drug quality. Since its establishment, Tasly has been independently exploring and upgrading its manufacturing technologies, establishing an intelligent manufacturing technology system. This has driven the development of Tasly’s TCM industry and aligns with the national strategic deployment for fostering new quality productive forces.

On the path to Chinese-style modernization, Traditional Chinese Medicine (TCM), as the crystallization of millennia-old wisdom of the Chinese nation, is revitalizing with unprecedented vigor. The rapid advancement of digital technology provides robust support and a broad platform for the modern transformation of TCM. Digital empowerment not only enables ancient TCM theories to shine anew with the aid of modern science and technology but also unlocks the immense potential and value of TCM within the health industry.

The deepening application of intelligent technologies is gradually transforming the production, research and development, service delivery, and management models of Traditional Chinese Medicine (TCM), enabling it to play a pivotal role in the development of new-quality productive forces. From the introduction of smart production lines to the application of big data analytics in the cultivation and quality control of TCM medicinal materials, and from the customization of personalized treatment plans to the provision of telemedicine services, digital technologies are driving the comprehensive upgrading and transformation of the TCM industry.

Looking ahead, Tasly will continue to join hands with digital and intelligent technologies, advancing toward innovation, intelligence, and the future. We firmly believe that, empowered by digital technology, Traditional Chinese Medicine (TCM) will contribute even more robust momentum to Chinese-style modernization. This not only enhances and inherits the intrinsic value of TCM but also demonstrates our contribution and responsibility to the global health cause. Let us work together to usher in a new chapter for TCM and contribute our wisdom and strength to building a global community of health for all.